Month: 7 月 2026

As part of its commitment to patient safety and regulatory compliance, Client needed a robust, automated solution for managing incoming safety case data from multiple global license partners. The goal was to streamline the process from intake to transmission into Argus Safety, while ensuring data accuracy, traceability, and timely acknowledgements.
With growing volumes of incoming cases—across multiple data formats (E2B R2 and R3)—an efficient, scalable solution was essential.

The Nextrove cross-functional team implemented fully automated intake and processing using Progressive Intake integrated with Argus Safety. The initiative focused on end-to-end automation and integrity of safety data flow.

Key components of the solution included:

• Automatic Identification & Import: Incoming cases in both E2B R2 and R3 formats are automatically detected and imported into Progressive Intake.
• Automated Acknowledgements: Immediate system-generated acknowledgements are sent to license partners upon import.
• Data Consistency & Traceability: Each case is assigned a Progressive Intake number while retaining the original license partner case number.
• Built-in Quality Controls: Duplicate detection, MedDRA coding, and QC checks are conducted within Progressive Intake before transmission.
• Seamless Integration with Argus Safety: Cases are automatically transmitted, fully populated in Argus Safety, and locked in the “Complete” workflow state.
• Feedback Loop Closure: Successful acceptance in Argus triggers acknowledgements back to Progressive Intake, with full documentation of both internal and partner reference numbers.

This initiative has transformed Client’s safety case intake process, yielding measurable improvements:

This project highlights the power of automation in pharmacovigilance operations. By integrating Progressive Intake with Argus Safety, the Nextrove team has delivered a scalable and efficient system that ensures regulatory compliance, enhances partner collaboration, and sets a new standard for safety data handling.

The success of this initiative reflects the dedication, innovation, and collaboration of the entire project team. Their work not only supports Client’s mission of patient safety but also reinforces Nextrove reputation as a forward-thinking leader in pharmacovigilance excellence.

In pharmacovigilance, proactive and well-documented follow-up is critical to enhancing case quality, ensuring regulatory compliance, and strengthening signal detection and risk management. Effective follow-up not only improves the completeness and accuracy of safety data but also contributes directly to better patient outcomes.

However, for many pharmaceutical organizations, follow-up management remains a resource-intensive process. Manual coordination, fragmented workflows, and inconsistent tracking can create operational bottlenecks that impact efficiency, data quality, and reporter engagement.

A top 10 global pharmaceutical company faced growing challenges in managing follow-up activities for adverse event reporting. The organization relied heavily on manual processes to coordinate follow-up requests across multiple teams and geographies.

The process was characterized by:

• Repetitive follow-up queries and communications
• Fragmented systems and disconnected workflows
• Labor-intensive tracking and documentation
• Reduced response rates from reporters
• Significant administrative burden consuming thousands of operational hours

To address these challenges, the company implemented Nextrove Progressive GFA, an automated and integrated follow-up management solution embedded directly within its safety database.

The solution streamlined the entire follow-up process by automating follow-up  queries generation, tracking, and response management while ensuring adherence to established business processes and regulatory requirements.

The implementation of Nextrove Progressive GFA generated substantial operational and quality improvements:

• 250,000 follow-ups generated from post-marketing experience cases
• More than 75% of generated follow-ups managed through the solution
• 30% reduction in processing time compared with manual follow-up workflows

By eliminating many of the administrative tasks associated with follow-up management, the organization significantly improved operational efficiency.

The automated and structured approach also improved the experience of healthcare professionals and other reporters.

Key benefits included:

• Enhanced reporter experience through simplified interactions
• Structured data capture instead of unstructured free-text responses
• Increased reporter engagement and response quality

These improvements contributed to more complete and actionable safety information while reducing the effort required from reporters.

From a business and compliance perspective, Nextrove Progressive GFA delivered significant advantages:

• Improved adherence to pharmacovigilance business processes and regulatory requirements
• Reduced resource utilization and material costs
• More accurate and consistent collection of safety data
• Enhanced case quality and data completeness
• Increased operational efficiency and measurable return on investment

Pharmacovigilance teams are under increasing pressure to manage growing case volumes while maintaining high standards of compliance and patient safety. Nextrove Progressive GFA transforms follow-up management from a manual, resource-intensive activity into an efficient, automated process that delivers measurable business value.

By improving reporter engagement, increasing data quality, and reducing operational burden, Nextrove Progressive GFA enables organizations to strengthen their pharmacovigilance operations while advancing their ultimate goal—protecting patient safety through better-informed decision-making.